rxstat › Classes › Other Beta-lactam Antibacterials

Other Beta-lactam Antibacterials: shortage status in Canada

9 of the 14 other beta-lactam antibacterials rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Cefaclor Widespread shortage 5 of 5 reported products affected Cefazolin Widespread shortage 1 of 13 reported products affected Cefepime Widespread shortage 2 of 3 reported products affected · est. return Sep 11, 2026 Cefixime (Suprax) Partial shortage 1 of 4 reported products affected · est. return Jul 31, 2026 Cefprozil (Cefzil) Partial shortage 1 of 16 reported products affected Ceftriaxone Partial shortage 1 of 15 reported products affected Cefuroxime (Ceftin -) Partial shortage 3 of 13 reported products affected Cephalexin Partial shortage 2 of 20 reported products affected · est. return Jul 31, 2026 Meropenem (Merrem) Partial shortage 2 of 11 reported products affected Cefadroxil No current shortage Cefotaxime (Claforan -) Discontinued 0 of 2 reported products affected Cefoxitin No current shortage Ceftazidime (Fortaz) No current shortage Ertapenem No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.